Methylprednisolone vs Pembrolizumab
Methylprednisolone vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Methylprednisolone and Pembrolizumab.
Mechanism of Action
Methylprednisolone: Intermediate-acting synthetic glucocorticoid.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Methylprednisolone — 18-36 hours; Pembrolizumab — 26 days.
Chemical Properties
Molecular Formula: Methylprednisolone — C22H30O5.
Molecular Weight: Methylprednisolone — 374.4710 g/mol.
Type: Methylprednisolone — Small molecule; Pembrolizumab — Antibody.